Lilly (LLY) Completes Acquisition of Morphic Aug 16, 2024 08:39AM
Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease Aug 16, 2024 08:38AM
Eli Lilly & Co. (LLY) to Acquire Morphic (MORF) for $57/sh Cash or $3.2B Jul 8, 2024 06:48AM
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease Jul 8, 2024 06:45AM
Citi Starts Morphic Therapeutic (MORF) at Buy Dec 8, 2023 05:53AM


Sep 1, 2021 08:00AM Morphic Therapeutic Announces Participation in September Investor Conferences
Sep 3, 2020 04:30PM Morphic Announces Participation in Upcoming Investor Conferences
Apr 7, 2020 08:00AM Morphic Announces Appointment of Marc Schegerin, M.D., as Chief Financial Officer and Chief Operating Officer
Apr 7, 2020 08:00AM Morphic Announces Appointment of Marc Schegerin, M.D., as Chief Financial Officer and Chief Operating Officer